• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重减轻和蛋白尿。

Weight loss and proteinuria.

作者信息

Praga Manuel, Morales Enrique

机构信息

Servicio de Nefrología, Hospital Universitario 12 de Octubre, Madrid, Spain.

出版信息

Contrib Nephrol. 2006;151:221-229. doi: 10.1159/000095332.

DOI:10.1159/000095332
PMID:16929145
Abstract

The level of proteinuria is one of the most determinant risk factors for the progression of proteinuric renal diseases. Several studies have shown that weight loss, either induced by low calorie diets, physical exercise, or bariatric surgery is accompanied by an important antiproteinuric effect. Reduction in proteinuria is already observed after a few weeks from the onset of weight loss and it is evident even in patients with modest weight losses. The magnitude of body weight loss and proteinuria decrease show a significant correlation. Reduction in proteinuria by weight loss has been described in obesity-induced glomerulopathy, obese diabetic patients and overweight or obese patients with different types of chronic proteinuric nephropathies. Attenuation of the obesity-induced glomerular hyperfiltration, decrease in the activity of renin-angiotensin-aldosterone system and modifications in the serum concentrations of adipocyte-derived cytokine are likely to be involved in the anti-proteinuric effect of weight loss, together with a better control of blood pressure, and improvement of serum lipid profile and insulin sensitivity.

摘要

蛋白尿水平是蛋白尿性肾脏疾病进展的最具决定性的危险因素之一。多项研究表明,通过低热量饮食、体育锻炼或减肥手术引起的体重减轻伴随着重要的抗蛋白尿作用。体重减轻开始几周后即可观察到蛋白尿减少,即使是体重减轻幅度不大的患者也是如此。体重减轻的幅度与蛋白尿减少之间存在显著相关性。体重减轻导致蛋白尿减少已在肥胖相关性肾小球病、肥胖糖尿病患者以及患有不同类型慢性蛋白尿性肾病的超重或肥胖患者中得到描述。肥胖引起的肾小球高滤过的减轻、肾素 - 血管紧张素 - 醛固酮系统活性的降低以及脂肪细胞衍生细胞因子血清浓度的改变,可能与体重减轻的抗蛋白尿作用有关,同时还能更好地控制血压、改善血脂谱和胰岛素敏感性。

相似文献

1
Weight loss and proteinuria.体重减轻和蛋白尿。
Contrib Nephrol. 2006;151:221-229. doi: 10.1159/000095332.
2
The effect of weight loss in obesity and chronic kidney disease.肥胖和慢性肾脏病患者体重减轻的效果。
Curr Hypertens Rep. 2012 Apr;14(2):170-6. doi: 10.1007/s11906-012-0247-x.
3
Therapeutic measures in proteinuric nephropathy.蛋白尿性肾病的治疗措施。
Kidney Int Suppl. 2005 Dec(99):S137-41. doi: 10.1111/j.1523-1755.2005.09925.x.
4
Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies.体重减轻对超重慢性蛋白尿性肾病患者的有益影响。
Am J Kidney Dis. 2003 Feb;41(2):319-27. doi: 10.1053/ajkd.2003.50039.
5
Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin-angiotensin-aldosterone system among patients with obesity and proteinuria.在肥胖和蛋白尿患者中,在传统肾素-血管紧张素-醛固酮系统阻滞剂基础上加用醛固酮拮抗剂的长期有益作用。
Nefrologia. 2015 Nov-Dec;35(6):554-61. doi: 10.1016/j.nefro.2015.09.008. Epub 2015 Oct 28.
6
[The antiproteinuric effect of the blockage of the renin-angiotensin-aldosterone system (RAAS) in obese patients. Which treatment option is the most effective? ].[肥胖患者中肾素-血管紧张素-醛固酮系统(RAAS)阻断的抗蛋白尿作用。哪种治疗方案最有效?]
Nefrologia. 2009;29(5):421-9. doi: 10.3265/Nefrologia.2009.29.5.5448.en.full.
7
Obesity-related glomerulopathy: body mass index and proteinuria.肥胖相关性肾小球病:体重指数与蛋白尿。
Clin J Am Soc Nephrol. 2010 Aug;5(8):1401-9. doi: 10.2215/CJN.01370210. Epub 2010 May 24.
8
Proteinuria-lowering effect of heparin therapy in diabetic nephropathy without affecting the renin-angiotensin-aldosterone system.肝素治疗对糖尿病肾病的降蛋白尿作用,且不影响肾素-血管紧张素-醛固酮系统。
Clin J Am Soc Nephrol. 2007 Jan;2(1):58-67. doi: 10.2215/CJN.02400706. Epub 2006 Dec 13.
9
Effects of weight loss on renal function in obese CKD patients: a systematic review.肥胖慢性肾脏病患者减肥对肾功能的影响:系统评价。
Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv82-98. doi: 10.1093/ndt/gft302. Epub 2013 Oct 2.
10
The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin a nephropathy: a randomized controlled trial.超重慢性蛋白尿性免疫球蛋白A肾病患者减重的有益效果:一项随机对照试验
J Ren Nutr. 2014 May;24(3):200-7. doi: 10.1053/j.jrn.2014.01.016.

引用本文的文献

1
Dapagliflozin's Effects on Urinary Albumin and Non-Albumin Proteins in Diabetic and Non-Diabetic Kidney Transplant Recipients.达格列净对糖尿病和非糖尿病肾移植受者尿白蛋白及非白蛋白蛋白的影响
Biomedicines. 2025 May 26;13(6):1303. doi: 10.3390/biomedicines13061303.
2
Lost and not found: randomized controlled trial of cognitive behavioral therapy for weight-loss in patients with chronic kidney disease.失而复“未”得:慢性肾病患者减肥认知行为疗法的随机对照试验
J Behav Med. 2025 Jun 19. doi: 10.1007/s10865-025-00583-w.
3
Association of the estimated glomerular filtration rate (eGFR) and/or proteinuria to predict the risk of initiation of dialysis in people with and without diabetes.
估计肾小球滤过率(eGFR)和/或蛋白尿与预测糖尿病患者和非糖尿病患者开始透析风险的关联。
Diabetol Int. 2022 Sep 13;14(1):86-93. doi: 10.1007/s13340-022-00603-z. eCollection 2023 Jan.
4
Animal Fat Intake Is Associated with Albuminuria in Patients with Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome.动物脂肪摄入与非酒精性脂肪性肝病和代谢综合征患者的白蛋白尿有关。
Nutrients. 2021 May 4;13(5):1548. doi: 10.3390/nu13051548.
5
Non-Alcoholic Fatty Liver Disease Is Associated with Kidney Glomerular Hyperfiltration in Adults with Metabolic Syndrome.非酒精性脂肪性肝病与代谢综合征成人患者的肾小球高滤过相关。
J Clin Med. 2021 Apr 16;10(8):1717. doi: 10.3390/jcm10081717.
6
A Novel Indoline Derivative Ameliorates Diabesity-Induced Chronic Kidney Disease by Reducing Metabolic Abnormalities.一种新型吲哚啉衍生物通过减轻代谢异常改善糖尿病肥胖诱导的慢性肾脏病。
Front Endocrinol (Lausanne). 2020 Mar 10;11:91. doi: 10.3389/fendo.2020.00091. eCollection 2020.
7
Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease.代谢综合征与慢性肾脏病在心血管疾病发展中的可能关联。
Cardiol Res Pract. 2010 Oct 7;2011:963517. doi: 10.4061/2011/963517.
8
Modulation of glomerulosclerosis.肾小球硬化的调节
Semin Immunopathol. 2007 Nov;29(4):385-95. doi: 10.1007/s00281-007-0087-y. Epub 2007 Sep 8.